EGFR and neoplasm: Therefore, we shed light on the effect of RA on ADAM17 expression and found that RA considerably inhibited the expression of ADAM17 together with the downstream mediators of ADAM17, which constitutes ADAM17/EGFR/AKT/GSK3β axis and represents a crucial pathway for tumor progression [12].